CORE Library Screening Compound Stock
The CORE Library small molecule screening compound stock is a total of more than 600,000 leadlike and druglike small molecule compounds based on novel scaffolds and designs created by ChemBridge. This stock includes 3D, sp3-enriched compounds and grows by approx. 80,000 compounds per year. Customer and custom select from the CORE Library stock.
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
The CORE Library small molecule screening compound stock is a total of more than 600,000 leadlike and druglike small molecule compounds based on novel scaffolds and designs created by ChemBridge.
This stock includes 3D, sp3-enriched compounds and grows by approx. 80,000 compounds per year. Customer and custom select from the CORE Library stock.
Brochures
ChemBridge Screening Compounds
Discover the benefits of ChemBridge Screening Compounds including their CORE library with over 590,000 compounds.
Learn More About ChemBridge: Corporate Profile
Interested in learning more about ChemBridge, check out their corporate profile.
Leveraging ChemBridge Libraries in Cancer Research
More than 1,500 articles cite the use of ChemBridge® small molecule screening libraries and compounds in a wide variety of research areas using high-throughput screening or focused screening following computer-aided screening. The list below highlights a small sampling of articles, from 2014 to present, that focus on work in cancer research and provides a sample of the different techniques employed and targets explored in hit finding and probe discovery using ChemBridge libraries and compounds.
